| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $423.2M | +56.6% |
| Cost of Revenue | $60.9M | +82.3% |
| R&D Expense | $111.6M | +46.7% |
| SG&A Expense | $168.0M | +29.8% |
| Operating Income | -$45.6M | -81.0% |
| Pre-tax Income | -$36.2M | -117.1% |
| Income Tax | $7.0M | +122.9% |
| Net Income | -$43.2M | -406.7% |
| EPS (Basic) | -$0.60 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $183.6M | +70.1% |
| Short-term Investments | $60.0M | -39.0% |
| Accounts Receivable | $41.7M | +96.2% |
| Inventory | $26.4M | -15.3% |
| Current Assets | $331.8M | +20.1% |
| Total Assets | $580.6M | +10.3% |
| Current Liabilities | $100.6M | +58.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.7M | +93.1% |
| Capital Expenditures | $277K | +113.1% |
| Investing Cash Flow | $37.7M | +227.5% |
| Financing Cash Flow | $12.3M | +720.5% |
| Free Cash Flow | $25.4M | +92.9% |
| -400.0% |
| EPS (Diluted) | -$0.60 | -400.0% |
| Total Liabilities |
| $142.1M |
| +62.5% |
| Stockholders' Equity | $438.4M | -0.1% |